Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/ déphosphorylation in plasma membrane from human epithelial ovarian cancer

Leung, 1992, Intracellular signaling in the gonads, Endocr Reo, 13, 476

Imai, 1992, Is extrapituitary action of gonadotropin-releasing hormone biologically significant?, Ann Clin Biochem, 29, 477, 10.1177/000456329202900501

Schally, 1984, Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers, Proc Soc Exp Biol Med, 175, 259, 10.3181/00379727-175-41797

Harris, 1989, Zolandex: endocrine and therapeutic effects in postmenopausal breast cancer, BrJCancer, 59, 97

Klijn, 1982, Treatment with a luteinizing hormone-releasing hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer, Lancet, i, 1213, 10.1016/S0140-6736(82)92339-X

Manni, 1986, Treatment of breast cancer with gonadotropin-releasing hormone, Endocr Rev, 7, 89, 10.1210/edrv-7-1-89

Waxman, 1985, The treatment of postmenopausal women with advanced breast cancer with buserelin, Cancer Chemother Pharmacol, 15, 171, 10.1007/BF00257531

Beland, 1990, A controUed trial of castration with and without Nilutamide in metastatic prostatic carcinoma, Cancer, 66, 1074, 10.1002/cncr.1990.66.s5.1074

Crawford, 1983, A controlled trial of leuprolide with and without fluramide in prostatic carcinoma, N Engl J Med, 321, 419, 10.1056/NEJM198908173210702

Huben, 1988, Investigators of the national prostatic cancer project: a comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate, Cancer, 62, 1881, 10.1002/1097-0142(19881101)62:9<1881::AID-CNCR2820620902>3.0.CO;2-9

Iversen, 1990, Zolandex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer, Cancer, 66, 1067, 10.1002/cncr.1990.66.s5.1067

Labrie, 1984, Simultaneous administration of pure anti-androgens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer, Proc Natt Acad Sei USA, 81, 3861, 10.1073/pnas.81.12.3861

Presant, 1985, Buserelin as primary therapy in advanced prostate carcinoma, Cancer, 56, 2416, 10.1002/1097-0142(19851115)56:10<2416::AID-CNCR2820561013>3.0.CO;2-#

Schröder, 1991, Hormonal manipulation of prostatic cancer: too soon for total androgen blockade?, Br Med J, 303, 1489, 10.1136/bmj.303.6816.1489

Smith, 1985, Clinical effects of gonadotropin releasing hormone analogues in metastatic carcinoma of the prostate, Urology, 25, 106, 10.1016/0090-4295(85)90523-0

Waxman, 1983, Treatment with gonadotrophin-releasing hormone analogue in advanced prostatic cancer, Br Med J, 286, 1309, 10.1136/bmj.286.6374.1309

Waxman, 1985, Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer, Br Med J, 291, 1387, 10.1136/bmj.291.6506.1387

Gallagher, 1991, A new treatment for endometrial cancer with gonadotropin releasing hormone analogue, Br J Obstet Gynecol, 98, 1037, 10.1111/j.1471-0528.1991.tb15343.x

Parmar, 1988, Response to D-Try-6-luteinizing hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer, Br Med J, 296, 1299, 10.1136/bmj.296.6631.1229

Gonzalez-Barcena, 1989, Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer, Biomed Pharmacother, 43, 313, 10.1016/0753-3322(89)90014-0

Greenway, 1987, Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?, Br J Surg, 74, 441, 10.1002/bjs.1800740602

Eidne, 1987, Gonadotropin-releasing hormone (GN-RH)-binding sites in human breast cancer cell lines and inhibitory effects of Gn-RH antagonists, J Clin Endocrinol Metab, 64, 425, 10.1210/jcem-64-3-425

Fekete, 1989, Membrane receptors for peptides in experimental and human pancreatic cancers, Pancreas, 4, 521, 10.1097/00006676-198910000-00001

Foekens, 1986, Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancers in vitro, Biochem Biophys Res Commun, 140, 50, 10.1016/0006-291X(86)90767-9

Miller, 1985, Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist, Nature, 313, 231, 10.1038/313231a0

Schally, 1987, Somatostatin analogs as adjunctions to agonists of luteinizing hormone in the treatment of experimental prostate cancer, Proc Natl Acad Sei USA, 84, 7275, 10.1073/pnas.84.20.7275

Sharoni, 1989, Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone, Proc Natl Acad Sei USA, 86, 1648, 10.1073/pnas.86.5.1648

Szende, 1989, Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinising hormone-releasing hormones and somatostatin, Proc Natl Acad Sei USA, 86, 1613, 10.1073/pnas.86.5.1643

Szende, 1990, Inhibitory effects of analogs of luteinizing hormone- releasing hormone and somatostatin on pancreatic cancers in hamsters, Cancer, 65, 2279, 10.1002/1097-0142(19900515)65:10<2279::AID-CNCR2820651020>3.0.CO;2-3

Szende, 1990, Regression of nitrosamine-mduced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists, Cancer Res, 50, 3716

Belisle, 1984, Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin.JClin, Endocrinol Metab, 59, 119, 10.1210/jcem-59-1-119

Eidne, 1985, Gonadotropin-releasing hormone binding sites in human breast carcinoma, Science, 229, 989, 10.1126/science.2992093

Emons, 1989, Gonadotropin-releasing hormone binding sites in human epithelial ovarian carcinoma, Eur J Cancer Clin Oncol, 25, 215, 10.1016/0277-5379(89)90011-4

Fekete, 1989, Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin and epidermal growth factor in cat and human prostate cancers and in benign prostate hyperplasia, Prostate, 14, 191, 10.1002/pros.2990140302

Fekete, 1989, Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor- binding ability to rat pituitary and human breast cancer membrane, Endocrinology, 124, 946, 10.1210/endo-124-2-946

Kadar, 1988, Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer, Prostate, 12, 299, 10.1002/pros.2990120403

Liebow, 1989, Somatostatin analogues inhibit growth of pancreatic cancer by stimulating thyrosine phosphatase, Proc Natl Acad Sei USA, 86, 2003, 10.1073/pnas.86.6.2003

Szende, 1991, Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells, Proc Natl Acad Sei USA, 88, 4153, 10.1073/pnas.88.10.4153

Srkalovic, 1989, Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma, Proc Soc Exp Biol Med, 192, 209, 10.3181/00379727-192-42987

Srkalovic, 1990, Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma, Cancer Res, 50, 1841

Berridge, 1989, Inositol phosphates and cell signalling, Nature, 341, 19, 10.1038/341197a0

Meldrum, 1991, The Ptdlns-PLC superfamily and signal transduction, Biochim Biophys Acta, 1092, 49, 10.1016/0167-4889(91)90177-Y

Rhee, 1989, Studies of inositol phospholipid-specific phospholipase C, Science, 244, 546, 10.1126/science.2541501

Iida, 1991, Stimulatory effects of estrogen on gonadotropin-releasing hormone-induced phosphoinositide tumover in granulosa cells, J Steroid Biochem, 38, 583, 10.1016/0960-0760(91)90316-W

Imai, 1992, Tight coupling of gonadotropin- releasing hormone receptor to stimulated phosphoinositide tumover and anti-gonadotropic action, Obstet Gynecol Invest, 33, 36, 10.1159/000294844

Imai, 1993, Gonadotropin-releasing hormone has a biphasic action on aromatase activity through protein kinase C in granulosa cells, Int J Fertil, 38, 50

Davis, 1982, Gonadotropin-releasing hormone (Gn-RH) rapidly stimulates the formation of inositol phosphates and diacylglycerol in rat granulosa cells: further evidence for the involvement of Ca2+ and protein kinase C in the action of Gn-RH, Endocrinology, 11, 1615

Shinohara, 1985, Inhibition of gonadotropin-induced granulosa cell differentiation by activation of protein kinase C, Proc Natl Acad Sei USA, 82, 8518, 10.1073/pnas.82.24.8518

Wang, 1989, Differential role of protein kinase C in the action of luteinizing hormone-releasing hormone on hormone production in rat ovarian cells, AmJObstet Gynecol, 160, 984

Velduis, 1986, An inhibitory role for the protein kinase C pathway in ovarian steroidogenesis: studies with cultured swine granulosa cells, Biochem J, 239, 505, 10.1042/bj2390505

Lee, 1991, Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of thyrosine residues of specific protein substrates in various tumors, Proc Natl Acad Sei USA, 88, 1656, 10.1073/pnas.88.5.1656

Szende, 1990, Growth inhibition of MXT mouse mammary tumor by the LH-RH antagonists SB-75, J Natl Cancer Inst, 82, 513, 10.1093/jnci/82.6.513

Liebow, 1991, Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation, Proc Natl Acad Sei USA, 88, 2244, 10.1073/pnas.88.6.2244

Imai, 1986, Differential regulation by phosphatidyl-inositol 4,5-bisphosphate of pituitary plasma membrane and cytosolic phosphoinositide kinases, Biochem J, 240, 341, 10.1042/bj2400341

Imai, 1987, Independent phosphatidy- linositol synthesis in rat pituitary plasma membrane and endoplasmic reticulum, Nature, 325, 725, 10.1038/325726a0

Evans, 1980, 103

Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6

Cohen, 1982, A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles, J Biol Chem, 257, 1523, 10.1016/S0021-9258(19)68224-4

Imai, 1987, Measurement of lipid tumover in response to TRH, Methods Enzymol, 141, 100, 10.1016/0076-6879(87)41059-8

Iwashita, 1986, Characterization of a gonadotropin-releasing hormone receptor site in term placenta and chorionic villi, J Clin Endocrinol Metab, 62, 127, 10.1210/jcem-62-1-127

Cantley, 1991, Oncogens and signal transduction, Cell, 64, 281, 10.1016/0092-8674(91)90639-G

Hunter, 1985, Protein-tyrosin kinases. Ann Rev, Biochem, 54, 897

Kock, 1991, SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins, Science, 252, 668, 10.1126/science.1708916

Reddy, 1992, Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor, Cancer Res, 52, 3636

Harris, 1991, Gonadotropin-releasing hormone gene expression in MDA- MB-231 and ZR-75–1 breast carcinoma cell line, Cancer Res, 51, 2577

Ohno T, Imai A, Furui T, Takahashi K, Tamaya T. Presence of gonadotropin-releasing hormone and its mRNA in human ovarian epithelial carcinoma. Am J Obstet Gynecol.